The Journal of Pediatrics
Volume 143, Issue 6 , Pages 725-730, December 2003

Oral prednisolone in the acute management of children age 6 to 35 months with viral respiratory infection-induced lower airway disease: a randomized, placebo-controlled trial

From the Paediatric Research Centre and Department of Pharmacy, University of Tampere School of Public Health and Research Unit, and the Department of Pharmacy, Tampere University Hospital, Tampere, Finland

Received 2 November 2002; received in revised form 5 June 2003; accepted 7 August 2003.

See editorial, p 700.

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 30.00 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.

 Supported by grants from the Emil Aaltonen Foundation; the Finnish Allergy Research Foundation; the Foundation for Pediatric Research, Finland; the Medical Research Fund of Tampere University Hospital; the Support Fund for the Department of Pediatrics; the Tampere University Research Foundation; and the Tuberculosis Foundation of Tampere.

PII: S0022-3476(03)00498-0

doi:10.1067/S0022-3476(03)00498-0

The Journal of Pediatrics
Volume 143, Issue 6 , Pages 725-730, December 2003